2200 N. Commerce Parkway
Variant is an emerging specialty pharmaceutical company leveraging advanced proprietary technologies to develop best-in-class drugs for patients with rare diseases.
Our accomplished leadership team, each with more than 15 years of demonstrated success in the biopharmaceutical and medical industries, focuses on assuring that our development efforts serve the needs of all our stakeholders: patients, health care providers, payors, and our investors.
Co-Founder and CEO: Stephen C. Glover
Acting CSO: Nicholas Labella, Jr. MS, RPh
Acting CMO: Pablo A. Guzman, MD, FACC
Acting VP, Development and Marketing: Karen Cashmere
Acting VP, Finance: Peter Wolfe
Acting VP, Corporate Development: Melda Uzbil
Please click here for Variant Pharma's pipeline.